Medtronic plc (MDT) EPS Basic: 3.73
Is Medtronic plc’s EPS basic high or low?
Medtronic plc's EPS basic of 3.73 is 15% above its 5-year average of 3.23, near the high end of its 5-year range (2.68–3.75).
1.08% above its 12-month average of 3.69.
MDT EPS Basic Chart
MDT Average EPS Basic Chart
MDT Current vs Average EPS Basic Chart
MDT EPS Basic Metrics
EPS BASIC
3.73
EPS BASIC AVG TTM
3.69
EPS BASIC AVG 3Y
3.25
EPS BASIC AVG 5Y
3.23
EPS BASIC AVG 10Y
3.10
EPS BASIC AVG 15Y
3.08
EPS BASIC AVG 20Y
2.88
CURRENT VS TTM AVG
+1.08%
CURRENT VS 3Y AVG
+14.95%
CURRENT VS 5Y AVG
+15.30%
CURRENT VS 10Y AVG
+20.18%
CURRENT VS 15Y AVG
+20.96%
CURRENT VS 20Y AVG
+29.45%
Medtronic plc EPS Basic Formula & Definition
EPS Basic is earnings per common share before the effect of potentially dilutive securities. It shows how much profit is attributable to each current common share.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Medtronic plc EPS Basic FAQ
- What is the EPS basic for Medtronic plc (MDT)?
- The EPS basic for MDT stock is 3.73.
- Is Medtronic plc's EPS basic high or low?
- Medtronic plc's EPS basic of 3.73 is 15% above its 5-year average of 3.23, near the high end of its 5-year range (2.68–3.75).
- What is the TTM average EPS basic for Medtronic plc (MDT)?
- The TTM average EPS basic for MDT stock is 3.69.
- What is the 3Y average EPS basic for Medtronic plc (MDT)?
- The 3Y average EPS basic for MDT stock is 3.25.
- What is the 5Y average EPS basic for Medtronic plc (MDT)?
- The 5Y average EPS basic for MDT stock is 3.23.
- What is the 10Y average EPS basic for Medtronic plc (MDT)?
- The 10Y average EPS basic for MDT stock is 3.10.
- What is the 15Y average EPS basic for Medtronic plc (MDT)?
- The 15Y average EPS basic for MDT stock is 3.08.
- What is the 20Y average EPS basic for Medtronic plc (MDT)?
- The 20Y average EPS basic for MDT stock is 2.88.
Medtronic plc EPS Basic History
| DATE | EPS BASIC |
|---|---|
| 2026-04-24 | 3.75 |
| 2025-04-30 | 3.63 |
| 2024-04-30 | 2.77 |
| 2023-04-30 | 2.83 |
| 2022-04-30 | 3.75 |
| 2021-04-30 | 2.68 |
| 2020-04-30 | 3.57 |
| 2019-04-30 | 3.44 |
| 2018-04-30 | 2.29 |
| 2017-04-30 | 2.92 |
| 2016-04-30 | 2.51 |
| 2015-04-30 | 2.44 |
| 2014-04-30 | 3.06 |
| 2013-04-30 | 3.40 |
| 2012-04-30 | 3.43 |
| 2011-04-30 | 2.87 |
| 2010-04-30 | 2.80 |
| 2009-04-30 | 1.85 |
| 2008-04-30 | 1.97 |
| 2007-04-30 | 2.44 |
| 2006-04-30 | 2.11 |
| 2005-04-30 | 1.49 |
| 2004-04-30 | 1.61 |
| 2003-04-30 | 1.31 |
| 2002-04-30 | 0.81 |
| 2001-04-30 | 0.87 |
| 2000-04-30 | 0.91 |
| 1999-04-30 | 0.40 |
| 1998-04-30 | 0.52 |
| 1997-04-30 | 0.51 |
Related Metrics
About Medtronic plc
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Geoffrey Straub Martha